文献
J-GLOBAL ID:201702281906691523
整理番号:17A1430284
再発性または難治性急性骨髄性白血病におけるgilteritinibによるFLT3の選択的阻害:多施設,初のヒト非盲検相1 2研究【Powered by NICT】
Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1-2 study
著者 (27件):
Perl Alexander E
(University of Pennsylvania-Abramson Comprehensive Cancer Center, Philadelphia, PA, USA)
,
Altman Jessica K
(Robert H Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, USA)
,
Cortes Jorge
(MD Anderson Cancer Center, Houston, TX, USA)
,
Smith Catherine
(Department of Leukemia, University of California at San Francisco, San Francisco, CA, USA)
,
Litzow Mark
(Mayo Clinic, Rochester, MN, USA)
,
Baer Maria R
(University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA)
,
Claxton David
(Penn State Milton S Hershey Medical Center, Hershey, PA, USA)
,
Erba Harry P
(Department of Internal Medicine, University of Alabama at Birmingham, Birmingham, AL, USA)
,
Gill Stan
(Astellas Pharma Global Development, Northbrook, IL, USA)
,
Goldberg Stuart
(Hackensack University Medical Center, Hackensack, NJ, USA)
,
Jurcic Joseph G
(Columbia University Medical Center, New York, NY, USA)
,
Larson Richard A
(Department of Medicine, University of Chicago, Chicago, IL, USA)
,
Liu Chaofeng
(Astellas Pharma Global Development, Northbrook, IL, USA)
,
Ritchie Ellen
(Weill Cornell Medical College, New York, NY, USA)
,
Schiller Gary
(David Geffen School of Medicine at UCLA, Los Angeles, CA, USA)
,
Spira Alexander I
(Virginia Cancer Specialists, Fairfax, VA, USA)
,
Strickland Stephen A
(Vanderbilt-Ingram Cancer Center, Nashville, TN, USA)
,
Tibes Raoul
(Mayo Clinic, Scottsdale, AZ, USA)
,
Tibes Raoul
(Department of Internal Medicine, Julius Maximilians University, Wuerzburg, Germany)
,
Ustun Celalettin
(Department of Internal Medicine, University of Minnesota, Minneapolis, MN, USA)
,
Wang Eunice S
(Roswell Park Cancer Institute, Buffalo, NY, USA)
,
Stuart Robert
(Medical University of South Carolina-Hollings Cancer Center, Charleston, SC, USA)
,
Rollig Christoph
(Department of Internal Medicine, Universitaetsklinikum TU Dresden, Dresden, Germany)
,
Neubauer Andreas
(Department of Internal Medicine, Universitaetsklinikum Giessen und Marburg, Marburg, Germany)
,
Martinelli Giovanni
(“L e A Seragnoli”, University of Bologna, Bologna, Italy)
,
Bahceci Erkut
(Astellas Pharma Global Development, Northbrook, IL, USA)
,
Levis Mark
(Department of Oncology, Johns Hopkins University, Baltimore, MD, USA)
資料名:
Lancet Oncology
(Lancet Oncology)
巻:
18
号:
8
ページ:
1061-1075
発行年:
2017年
JST資料番号:
W1266A
ISSN:
1470-2045
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)